List
March 23rd, 2016

Bioequivalence studies of angiotensin converting enzyme inhibitors: Part – I (lisinopril)

[No abstract available]

March 23rd, 2016

Stability indicating reverse phase HPLC method for acyclovir

A simple, rapid and selective stability indicating HPLC method has been developed for quantitation of acyclovir in pharmaceutical dosage forms […]

March 23rd, 2016

Estimation of Sumatriptan succinate in pharmaceutical dosage form by spectrophotometric and HPTLC method

Two rapid, simple and accurate analytical methods have been developed for the quantitative estimation of Sumatriptan succinate (SMT) in pharmaceutical […]

March 23rd, 2016

Inclusion Complexation of Ketoprofen with β-Cyclodextrins

Ketoprofen, a non-steroidal anti-inflammatory agent, is chemically a propionic acid derivative having poor aqueous solubility. This study describes method of […]

March 23rd, 2016

Quercetin-cyclodextrin complex and it’s chemotherapeutic investigations in cancer

Quercetin is a widely distributed bioflavonoid which inhibits the growth of tumour cells. The present study was designed to investigate […]

March 23rd, 2016

Bioequivalence studies of angiotensin converting enzyme inhibitors: Part VIII – Pharmacokinetic interaction between captopril and hydrochlorthiazide

A single dose complete crossover study of a combined dosage form of Captopril (25 mg) and hydrochlorthiazide (12.5 mg) marketed […]

March 23rd, 2016

Bioequivalence studies of angiotensin converting enzyme inhibitors. Part VII (captopril)

A single dose complete crossover study of captopril (25 mg) conventional formulation to be marketed in India was carried out […]

March 23rd, 2016

Bioequivalence studies of angiotensin converting enzyme inhibitors: Part V – Pharmacokinetic interaction between lisinopril and hydrochlorothiazide

A single dose complete crossover study of combined dosage form of Lisinopril (5 mg) and hydrochlorothiazide (12.5 mg) marketed in […]

March 23rd, 2016

Pharmacokinetic studies of new angiotensin converting enzyme inhibitors marketed abroad – Part VI (Quinapril, Benazepril and Trandolapril)

Pharmacokinetic studies of Trandolapril (2 mg), Benazepril (5 mg) and Quinapril (20 mg), marketed abroad was carried out on eight […]

March 23rd, 2016

Polymeric nanoparticle formulation of octapeptide (NP-OP): In vitro release and in vivo effect in common marmosets, Callithrix jacchus Linn

Octapeptide (OP)/FSH-Receptor Binding Inhibitor-8 (FRBI-8), is a synthetic peptide corresponding to N-terminal sequence of purified fraction of Follicle Stimulating Hormone […]